|
Dramatic rise in chemo spending
Oncology Update Just six medicines made up 58% of all chemotherapy costs in 2011: new medications rituximab, imatinib, bevacizumab and trastuzumab, and the older, generic medications docetaxel and paclitaxel. Dr Vitry said it “very surprising” to discover that such a … |
|
Creating synthetic antibodies
MIT News To create these “synthetic antibodies,” the researchers used carbon nanotubes — hollow, nanometer-thick cylinders made of carbon that naturally fluoresce when exposed to laser light. In the past, researchers have exploited this phenomenon to create … |
ASH 2013 Preview: Novel Immunotherapies Under Development For The …The Myeloma Beacon… then had their regulatory T cells removed via treatment of the patients with an antibody called Simulect (basiliximab), and three patients underwent transplantat…
|
Gilead Sciences, Inc. : Gilead’s Idelalisib Significantly Reduces Rate of …
4-traders (press release) (BUSINESS WIRE)–Nov. 18, 2013– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Phase 3 study (Study 116) evaluating idelalisib in combination with rituximab in previously-treated chronic lymphocytic leukemia (CLL) patients … |
|
Investors Alert: Amgen, Inc. (NASDAQ:AMGN), Galena Biopharma Inc (NASDAQ …
Market News Call 18 announced that the company’s Phase 3 study (Study 116) evaluating idelalisib in combination with rituximab in previously-treated chronic lymphocytic leukemia (CLL) patients who were not fit for chemotherapy was accepted for presentation during a … |
Laboratory Equipment |
Linking Antibodies to Diseases Sheds Light on Conditions
Laboratory Equipment By cross referencing the amino acid sequence of peptides strongly associated with illnesses with a library You may be sensitive to gluten, but you’re not sure. Perhaps you can’t put your finger on a recurring malaise, and your doctor is at a loss to … |
|
SCT, AB Biosciences Collaborate on Antibodies Using NGS
GenomeWeb NEW YORK (GenomeWeb News) – Single Cell Technology and AB Biosciences today announced a collaboration aimed at identifying therapeutic antibodies. SCT will use its technology called Antibody Biologix to massively screen plasma cells and measure … Single Cell Technology and AB Biosciences Announce CollaborationHispanicBusiness.com |
NoozhawkBreaking the Code: UCSB Researchers Link Antibodies to Certain DiseasesNoozhawkBy cross referencing the amino acid sequence of peptides strongly associated with illnesses with a library of known peptides, researchers may be able to map antigens…
Creating biochemical reagents that can accurately detect disease-associated …Phys.OrgBy cross-referencing the amino acid sequence of peptides strongly associated with illnesses with a library of known peptides, researchers may be able to map antigens…
Research and Markets: Global Cancer Monoclonal Antibodies Pipeline AnalysisBusiness Wire (press release)In the past few years monoclonal antibodies have emerged as a therapeutic modality for cancer. These monoclonal antibodies are designed to selective…